A defining 2026 milestone in the industry is the mass deployment of Multiplex Rapid Tests. In 2026, the market is identifying a shift away from "single-disease" kits toward devices that can screen for Malaria, Dengue, and Chikungunya from a single drop of blood. This 2026 strategy is vital because it addresses the diagnostic dilemma faced by rural doctors during the monsoon season, where...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek